Mpirik Appoints Medtech Industry Veterans Paul Mirabella and Hooman Hakami to Company's Board of Directors
MILWAUKEE, June 18, 2020 /PRNewswire/ -- Mpirik, an A.I. healthcare technology company that develops automated patient screening models for cardiovascular disease to drive actionable knowledge, quality and research, has named Paul Mirabella and Hooman C. Hakami to its Board of Directors.
Mr. Mirabella has more than 40 years of experience in the healthcare industry most notably as President and CEO of GE Healthcare's Global Diagnostic Imaging business. He is currently an independent director and investor in several healthcare businesses, a limited partner in Venture Capital and Private Equity funds spanning Healthcare, Technology, Energy, Real Estate and Food Safety. After retiring from GEHC, he led Naviscan, Inc. a diagnostic imaging start-up, as Chairman and CEO.
Mr. Mirabella holds a B.S. in Aerospace Engineering and Applied Mechanics from Polytechnic Institute in New York, an M.S. in Mechanical Engineering from the University of Central Florida and is a graduate of multiple GE Business Management Development Programs.
"In late 2018, I had the opportunity to do some business consulting for Mpirik. The more I looked and learned, the more convinced I was that Mpirik's unique technology would not only make a huge impact on correcting the misdiagnosis and treatment of Severe Aortic Stenosis, but the monetization of the accessed data represented a once-in-a-lifetime opportunity for growth."
Mr. Hakami has 30 years of leadership experience. He is currently the Managing Director of Hakami Healthcare Advisors, LCC where he provides advisory services to Boards and CEOs in the healthcare space. Previously, he was with Medtronic, where he served as Executive Vice President and President of the Diabetes Group. Prior to Medtronic, he spent more than 20 years at General Electric, where he was a Company Officer.
"I am very excited to join the Mpirik Board. Mpirik's technology can make a real difference in healthcare. Using AI and decision support, it can capture and analyze massive amounts of both qualitative and quantitative data to ensure the right patients get the right care at the right time. What makes Mpirik unique is that their services add value for all stakeholders in the healthcare ecosystem - physicians, hospitals, insurers and, most of all, patients."
"We are thrilled to have Paul and Hooman join the Mpirik Board of Directors," said Joe Kohli, MD, Founder and Chief Executive Officer of Mpirik. "They bring global management and medical industry expertise that will provide the Board instrumental strategic guidance as we navigate through our next phase of growth."
About Mpirik
Mpirik is the developer of a healthcare intelligence platform designed to identify critical findings, filter extraneous data and facilitates communication. The company's platform collects and aggregates health data, standardizes patient communication and tracks patients through the progression of the disease and ensures that patients receive a proper and timely follow-up, enabling clinicians to deliver excellence by objectively screening patients for disease with the consistency of a computer algorithm.
View original content:http://www.prnewswire.com/news-releases/mpirik-appoints-medtech-industry-veterans-paul-mirabella-and-hooman-hakami-to-companys-board-of-directors-301078718.html
SOURCE Mpirik
